251 related articles for article (PubMed ID: 26560121)
1. Regulation of Epithelial-Mesenchymal Transition by E3 Ubiquitin Ligases and Deubiquitinase in Cancer.
Inoue Y; Itoh Y; Sato K; Kawasaki F; Sumita C; Tanaka T; Morishita D; Hayashi H
Curr Cancer Drug Targets; 2016; 16(2):110-8. PubMed ID: 26560121
[TBL] [Abstract][Full Text] [Related]
2. Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors.
Xu M; Zhu C; Zhao X; Chen C; Zhang H; Yuan H; Deng R; Dou J; Wang Y; Huang J; Chen Q; Jiang B; Yu J
Oncotarget; 2015 Jan; 6(2):979-94. PubMed ID: 25460509
[TBL] [Abstract][Full Text] [Related]
3. The SCF-type E3 Ubiquitin Ligases as Cancer Targets.
Kitagawa K; Kitagawa M
Curr Cancer Drug Targets; 2016; 16(2):119-29. PubMed ID: 26560120
[TBL] [Abstract][Full Text] [Related]
4. Targeting CSC-related transcription factors by E3 ubiquitin ligases for cancer therapy.
Wang W; Liu W; Chen Q; Yuan Y; Wang P
Semin Cancer Biol; 2022 Dec; 87():84-97. PubMed ID: 36371028
[TBL] [Abstract][Full Text] [Related]
5. The role of aberrant proteolysis in lymphomagenesis.
Sahasrabuddhe AA; Elenitoba-Johnson KS
Curr Opin Hematol; 2015 Jul; 22(4):369-78. PubMed ID: 26049759
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitination and the Ubiquitin-Proteasome System as regulators of transcription and transcription factors in epithelial mesenchymal transition of cancer.
Voutsadakis IA
Tumour Biol; 2012 Aug; 33(4):897-910. PubMed ID: 22399444
[TBL] [Abstract][Full Text] [Related]
7. The ubiquitin ligase TRIM56 inhibits ovarian cancer progression by targeting vimentin.
Zhao L; Zhang P; Su XJ; Zhang B
J Cell Physiol; 2018 Mar; 233(3):2420-2425. PubMed ID: 28771721
[TBL] [Abstract][Full Text] [Related]
8. Deubiquitinating enzyme inhibitors and their potential in cancer therapy.
Crosas B
Curr Cancer Drug Targets; 2014; 14(6):506-16. PubMed ID: 25088039
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the protein stability of EMT transcription factors.
Díaz VM; Viñas-Castells R; García de Herreros A
Cell Adh Migr; 2014; 8(4):418-28. PubMed ID: 25482633
[TBL] [Abstract][Full Text] [Related]
10. [The role of different E3 ubiquitin ligases in regulation of the P53 tumor suppressor protein].
Daks AA; Melino D; Barlev NA
Tsitologiia; 2013; 55(10):673-87. PubMed ID: 25509121
[TBL] [Abstract][Full Text] [Related]
11. The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer.
Chen A; Wong CS; Liu MC; House CM; Sceneay J; Bowtell DD; Thompson EW; Möller A
Oncotarget; 2015 Jan; 6(2):862-73. PubMed ID: 25528765
[TBL] [Abstract][Full Text] [Related]
12. E3 Ubiquitin Ligases as Molecular Targets in Human Oral Cancers.
Masumoto K; Kitagawa M
Curr Cancer Drug Targets; 2016; 16(2):130-5. PubMed ID: 26560119
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
[TBL] [Abstract][Full Text] [Related]
14. F-box proteins: Keeping the epithelial-to-mesenchymal transition (EMT) in check.
Díaz VM; de Herreros AG
Semin Cancer Biol; 2016 Feb; 36():71-9. PubMed ID: 26506454
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
16. Tribbles-Related Protein Family Members as Regulators or Substrates of the Ubiquitin-Proteasome System in Cancer Development.
Sakai S; Miyajima C; Uchida C; Itoh Y; Hayashi H; Inoue Y
Curr Cancer Drug Targets; 2016; 16(2):147-56. PubMed ID: 26560117
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of ubiquitin ligases in cancer.
Qi J; Ronai ZA
Drug Resist Updat; 2015 Nov; 23():1-11. PubMed ID: 26690337
[TBL] [Abstract][Full Text] [Related]
18. Snail regulated by PKC/GSK-3β pathway is crucial for EGF-induced epithelial-mesenchymal transition (EMT) of cancer cells.
Liu ZC; Chen XH; Song HX; Wang HS; Zhang G; Wang H; Chen DY; Fang R; Liu H; Cai SH; Du J
Cell Tissue Res; 2014 Nov; 358(2):491-502. PubMed ID: 25124796
[TBL] [Abstract][Full Text] [Related]
19. Deubiquitinase USP29 promotes gastric cancer cell migration by cooperating with phosphatase SCP1 to stabilize Snail protein.
Qian W; Li Q; Wu X; Li W; Li Q; Zhang J; Li M; Zhang D; Zhao H; Zou X; Jia H; Zhang L; Yang XD; Hou Z
Oncogene; 2020 Oct; 39(44):6802-6815. PubMed ID: 32973332
[TBL] [Abstract][Full Text] [Related]
20. DYRK2 controls the epithelial-mesenchymal transition in breast cancer by degrading Snail.
Mimoto R; Taira N; Takahashi H; Yamaguchi T; Okabe M; Uchida K; Miki Y; Yoshida K
Cancer Lett; 2013 Oct; 339(2):214-25. PubMed ID: 23791882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
